Sun Pharma shares rose sharply on Sunday after the company reported a 16% YoY rise in Q3 net profit to Rs 3,369 crore, supported by strong India business and improved margins. The firm also declared an interim dividend of Rs 11 per share, further boosting sentiment despite cautious institutional activity.
NFO flows hit a 5-year low in June quarter, SIPs stay robust
New fund offer collections by asset management companies fell significantly. Funds raised through new fund offers reached a five-year low in June. This sharp decline